Winter et al., in their evaluation of 127 patients who underwent resection for PDA, found no association between SMAD4 expression and PDA recurrence (P = 0.9) or death (P = 0.15) [50]. This evidence concerns the gene SMAD4 and Patent ductus arteriosus.